Clinical Trial

PIBD-SETQuality: the Inception Cohort and Safety Registry

Study acronym: PIBD-SETQ
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to analyse effectiveness and safety signals of current treatment strategies in routine practice for patients with pediatric-onset inflammatory bowel disease (PIBD) and to correlate this to their individual risk factors.
Protocol Amendment History 3 changes
notable Sponsor changed: PIBD-Net -> Erasmus Medical Center 2026-08-12
notable Primary completion pushed: 2027-12-31 -> 2030-12-31 2026-08-12
minor Completion pushed: 2027-12-31 -> 2030-12-31 2026-08-12
Trial Details
NCT Number NCT03571373
Lead Sponsor Erasmus Medical Center
Collaborators: European Commission, Queen Mary University of London, Hôpital Necker-Enfants Malades, Paris
Conditions Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
Enrollment 1,500 participants
Start Date 2017-01-03
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-11